D.E. Shaw & Co’s Amedisys AMED Stock Holding History

D.E. Shaw & Co’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,078	Closed	-$283K	–	4509
2024 Q2	$283K	Sell	3,078 -1,414	-31%	-$131K	﹤0.01%	3929
2024 Q1	$414K	Hold	4,492	–	–	﹤0.01%	3573
2023 Q4	$427K	Sell	4,492 -10,881	-71%	-$1.02M	﹤0.01%	3591
2023 Q3	$1.44M	Sell	15,373 -190,987	-93%	-$17.6M	﹤0.01%	2830
2023 Q2	$18.9M	Sell	206,360 -53,800	-21%	-$4.41M	0.02%	903
2023 Q1	$19.1M	Buy	260,160 +59,291	+30%	+$5.13M	0.02%	922
2022 Q4	$16.8M	Buy	200,869 +48,092	+31%	+$4.34M	0.02%	1037
2022 Q3	$14.8M	Sell	152,777 -45,624	-23%	-$5.44M	0.02%	1052
2022 Q2	$20.9M	Sell	198,401 -103,790	-34%	-$13.3M	0.02%	842
2022 Q1	$52.1M	Sell	302,191 -221,656	-42%	-$33.1M	0.05%	477
2021 Q4	$84.8M	Sell	523,847 -129,301	-20%	-$20.8M	0.07%	333
2021 Q3	$97.4M	Buy	653,148 +272,576	+72%	+$56.7M	0.09%	266
2021 Q2	$93.2M	Buy	380,572 +60,932	+19%	+$16M	0.08%	294
2021 Q1	$84.6M	Buy	319,640 +21,246	+7%	+$5.99M	0.08%	286
2020 Q4	$87.5M	Buy	298,394 +557	+0.2%	+$143K	0.08%	307
2020 Q3	$70.4M	Buy	297,837 +17,391	+6%	+$3.95M	0.07%	314
2020 Q2	$55.7M	Sell	280,446 -167,387	-37%	-$31.2M	0.07%	334
2020 Q1	$82.2M	Buy	447,833 +72,499	+19%	+$12.9M	0.13%	172
2019 Q4	$62.6M	Sell	375,334 -59,612	-14%	-$8.87M	0.07%	320
2019 Q3	$57M	Sell	434,946 -11,995	-3%	-$1.56M	0.07%	344
2019 Q2	$54.3M	Buy	446,941 +76,403	+21%	+$9.07M	0.07%	352
2019 Q1	$45.7M	Buy	370,538 +90,378	+32%	+$11.3M	0.06%	407
2018 Q4	$32.8M	Sell	280,160 -80,058	-22%	-$9.44M	0.05%	488
2018 Q3	$45M	Sell	360,218 -185,388	-34%	-$20.5M	0.05%	441
2018 Q2	$46.6M	Sell	545,606 -67,799	-11%	-$4.98M	0.06%	389
2018 Q1	$37M	Sell	613,405 -24,112	-4%	-$1.37M	0.05%	436
2017 Q4	$33.6M	Buy	637,517 +134,151	+27%	+$7.07M	0.05%	467
2017 Q3	$28.2M	Buy	503,366 +171,783	+52%	+$9.08M	0.04%	490
2017 Q2	$20.8M	Buy	331,583 +65,508	+25%	+$3.82M	0.03%	576
2017 Q1	$13.6M	Buy	266,075 +16,523	+7%	+$788K	0.02%	755
2016 Q4	$10.6M	Buy	249,552 +91,620	+58%	+$3.9M	0.02%	913
2016 Q3	$7.49M	Sell	157,932 -132,384	-46%	-$6.61M	0.01%	1050
2016 Q2	$14.7M	Sell	290,316 -57,080	-16%	-$2.88M	0.03%	674
2016 Q1	$16.8M	Sell	347,396 -73,325	-17%	-$2.83M	0.03%	616
2015 Q4	$16.5M	Sell	420,721 -88,066	-17%	-$3.52M	0.02%	727
2015 Q3	$19.3M	Sell	508,787 -209,557	-29%	-$8.84M	0.03%	630
2015 Q2	$28.5M	Sell	718,344 -102,593	-12%	-$3.2M	0.04%	496
2015 Q1	$22M	Sell	820,937 -125,887	-13%	-$3.55M	0.03%	572
2014 Q4	$27.8M	Buy	946,824 +423,711	+81%	+$10.5M	0.04%	560
2014 Q3	$10.6M	Buy	523,113 +111,871	+27%	+$2.16M	0.01%	1046
2014 Q2	$6.88M	Sell	411,242 -87,353	-18%	-$1.24M	0.01%	1370
2014 Q1	$7.42M	Sell	498,595 -56,851	-10%	-$875K	0.01%	1263
2013 Q4	$8.13M	Buy	555,446 +10,792	+2%	+$174K	0.01%	1295
2013 Q3	$9.38M	Buy	544,654 +505,560	+1,293%	+$7.5M	0.02%	1066
2013 Q2	$455K	Buy	+39,094	New	+$448K	﹤0.01%	3310

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's AMED Position: Q3 2024 in Review

D.E. Shaw & Co sold out of Amedisys (AMED) in Q3 2024, closing a stake of 3,078 shares — an estimated $283K sold.

D.E. Shaw & Co first reported a position in AMED in Q2 2013 and held it in 45 quarters. The position peaked at $97.4M in Q3 2021. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

D.E. Shaw & Co reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
D.E. Shaw & Co sold 3,078 Amedisys shares in Q3 2024, an estimated $283K.
D.E. Shaw & Co first reported a position in Amedisys in Q2 2013 and held it in 45 quarters.
D.E. Shaw & Co's Amedisys position peaked at $97.4M in Q3 2021.
285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.